Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Dubois

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bio Systems|January 1, 1997
Generation of fractals from incursive automata, digital diffusion and wave equation systemsD M Dubois
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1975
Molecular model of postsynaptic potentialD M Dubois, E Schoffeniels
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1974
A molecular model of action potentialsD M Dubois, E Schoffeniels
British Journal of Clinical Pharmacology|June 1, 1983
Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysisB L Flouvat, C Imbert, D M Dubois, et al.
Journal of Clinical Anesthesia|April 25, 2000
Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study GroupB K Philip, C H McLeskey, J E Chelly, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 1998
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trialsJ B Whitmore, M G Kris, P J Hesketh, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bio Systems|January 1, 1997
Generation of fractals from incursive automata, digital diffusion and wave equation systemsD M Dubois
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1975
Molecular model of postsynaptic potentialD M Dubois, E Schoffeniels
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1974
A molecular model of action potentialsD M Dubois, E Schoffeniels
British Journal of Clinical Pharmacology|June 1, 1983
Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysisB L Flouvat, C Imbert, D M Dubois, et al.
Journal of Clinical Anesthesia|April 25, 2000
Pooled analysis of three large clinical trials to determine the optimal dose of dolasetron mesylate needed to prevent postoperative nausea and vomiting. The Dolasetron Prophylaxis Study GroupB K Philip, C H McLeskey, J E Chelly, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 1998
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting. Pooled analysis of 14 clinical trialsJ B Whitmore, M G Kris, P J Hesketh, et al.
Pageof 1